Merck tried to bury Vioxx concerns for years
“Internal e-mails and other documents from Merck & Co. show the company fought for years to keep safety concerns from undermining the drug’s commercial prospects, the Wall Street Journal reported on Monday.”
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
